Abstract N6-methyladenosine (m6A) RNA methylation is the predominant epigenetic
modification for mRNAs that regulates various cancer-related pathways. However, the …

Epilepsy is a common neurological disorder characterized by recurrent seizures with
excessive and abnormal neuronal discharges. Epileptogenesis is usually involved in …

This review navigates the evolving landscape of N6‐methyladenosine (m6A) research
approaches, emphasizing the importance of advanced technology in understanding RNA …

N 6-Methyladenosine (m6A) is a prevalent and highly regulated RNA modification essential
for RNA metabolism and normal brain function. It is particularly important in the …

Alterations in autophagy have been observed in epilepsy, although their exact
etiopathogenesis remains elusive. Transient Receptor Potential Mucolipin Protein 1 …

Background Abnormal methylation of N 6-methyladenosine (m6A) is reportedly associated
with central nervous system disorders. However, the role of m6A mRNA methylation in …

Major depressive disorder (MDD) is a prevalent psychiatric condition often accompanied by
severe impairments in cognitive and functional capacities. This research was conducted to …

Epilepsy is a common neurological disorder which can cause significant morbidity and
mortality. N6-methyladenosine (m6A), the most common chemical epigenetic modification …

Gliomas, the most prevalent malignant brain tumors in the central nervous system, are
marked by rapid growth, high recurrence rates, and poor prognosis. Glioblastoma (GBM) …

Abstract N6-methyladenosine (m 6 A), the most prevalent and conserved RNA modification
in eukaryotic cells, profoundly influences virtually all aspects of mRNA metabolism. mRNA …